Dear colleagues & prospective Ph.D. students,  

 

The Technische Universität Braunschweig in collaboration with Helmholtz Centre for Infection Research and Ostfalia University of Applied Sciences currently initiate the doctoral program "Drug Discovery and Cheminformatics for New Anti-Infectives (iCA)“ which is granted by the Ministry of Science and Culture of Lower Saxony.  The program aims at studying fundamental principles of drug discovery by combining life sciences and digital sciences.

 

The iCA consortium is offering 15 Georg-Christoph-Lichtenberg scholarships (duration: 3 years).

 

The program of the iCA consortium offers an ambitious, structured and interdisciplinary training based on top-level fundamental research. This joint program provides an internationally competitive research environment with state-of-the-art facilities. The participating groups use a variety of different methods, including experimental, digital, and theoretical approaches.

 

More information about specific projects and participating groups can be found at:

https://www.tu-braunschweig.de/en/pharmchem/translate-to-english-promotionsprogramm-ica

 

The graduate program starts in the period from February to July 2020. For details and individual project descriptions please refer to the scholarship announcement attached. If you have any questions, please contact [email protected].

 

The program is open for applications now. Applications should include letter of motivation, curriculum vitae, certificates, etc. combined in a single PDF file (max. 15 MB). Please send your application to [email protected] until 31 December, 2019.

 

Please forward these information to interested colleagues.

 

Kind regards,

 

 

Wulf Blankenfeldt